CaaMTech is pioneering next-generation psychedelic drugs for the 21st century.
Location: United States, Washington, Issaquah
Employees: 1-10
Total raised: $22M
Founded date: 2019
Investors 2
| Date | Name | Website |
| - | Kortschak ... | kortschak.... |
| - | Noetic Fun... | noeticfund... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.09.2021 | Series A | $22M | - |
Mentions in press and media 5
| Date | Title | Description |
| 27.03.2023 | Here are the 15 hottest startups in the psychedelics industry, according to top investors | From left: Sherry Rais, a cofounder and the CEO of Enthea; Mark Rus, the CEO of Delix Therapeutics; Jackie von Salm, a cofounder and the CSO of Psilera; Jimmy Qian, a cofounder and the president of Osmind. Sherry Rais/Enthea; Mark Rus/Delix... |
| 10.09.2021 | Seattle-area psychedelics startup CaaMTech raises $22M to advance to human testing | CaaMTech aims to take the uncertainty out of psychedelics like magic mushrooms and provide defined formulations. (BigStock Photo) CaaMTech, a Seattle-area startup developing new psychedelic agents, has raised $22 million in funding, the com... |
| 09.09.2021 | CaaMTech Raises $22M in Series A Funding | CaaMTech, an Issaquah, WA-based psychedelic drug discovery company, raised $22M in Series A funding. The round was led by Noetic Fund. The company intends to use the funds to support its cross-disciplinary science program, expand its leader... |
| 08.09.2021 | CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development | ISSAQUAH, Wash., Sept. 08, 2021 (GLOBE NEWSWIRE) -- CaaMTech, Inc., a leading psychedelic drug discovery company, has today announced the completion of a $22 million Series A financing round, led by Noetic Fund. The oversubscribed round of ... |
| 28.02.2020 | CULTIVATED: Border towns boom, Wall Street warns against Canadian stocks, MedMen earnings, and more | Associated Press Employees prune marijuana plants. Advertisement Welcome to Cultivated, our weekly newsletter where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis bo... |